News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Nicholas Sarlis: ‘Must read” article in this week’s ‘Cancer Letter’
Photo from Nicholas Sarlis/LinkedIn
Mar 3, 2024, 16:47

Nicholas Sarlis: ‘Must read” article in this week’s ‘Cancer Letter’

Nicholas Sarlis, Chief Medical Officer at Cleara Biotech, shared a post on LinkedIn:

“‘Must read” article in this week’s ‘Cancer Letter’. A true milestone for the IO field.”

Source: Nicholas Sarlis/LinkedIn

cancer Cancer Letter immune-oncology immunotherapy IO Nicholas Sarlis OncoDaily Oncology
Special Coverage
Blog
May 9, 2025, 20:14
Catherine Alix-Panabières: Amazing 3rd General Assembly of the European GUIDE.MRD IHI Project
Blog
May 9, 2025, 19:44
Amanda Impellizzeri: MCED Act Just Hit a Historic Milestone
Blog
May 9, 2025, 19:25
Sondus Alsharidah: Building Bridges in Pediatric Oncology and Oncology Care
Blog
May 9, 2025, 19:03
Rasha Aboelhassan: Have you ever felt like everything is going so smoothly, and your dreams are coming true?
Blog
May 9, 2025, 18:51
Emma Walmsley: GSK Medics Are Accelerating the Partnerships We Need
Insight
May 9, 2025, 18:09
Katsuaki Maehara Highlights TIM-3 as a Potential Target for Lung Adenocarcinoma Precancer Interception
Societies
May 9, 2025, 18:03
Who From Oncology is Featured in TIME100 Health 2025?
Blog
May 9, 2025, 17:53
Jill Barnholtz-Sloan: It Takes Everyone on the Team to Fulfill the Mission of the NCI to End Cancer
Blog
May 9, 2025, 17:45
AstraZeneca Unveils $300M Cell Therapy Facility in Rockville to Boost CAR-T Cell Therapy Production
Blog
May 9, 2025, 17:38
Matthew Mifsud Highlights USF ENT and TGH Cancer Institute 2025 Head and Neck Cancer Symposium
Blog
May 9, 2025, 17:23
Jan-Henning Klusmann: RNA Innovation in Focus – Retreat of the DFG Research Unit RU5433
Insight
May 9, 2025, 17:19
Bishal Gyawali: I Hope Trial Sponsors and Trialists Will Find These Results Helpful and Meaningful